Annually, $88.2 million is spent on hemophilia care and treatment. Currently there are 8,500 hemophiliacs in the country, said Seyed Mohammad Hadi Ayazi, deputy health minister for social affairs, non-government organizations and health charities.
At present, hemophilia medication constitutes one-third of pharmaceutical imports, IRNA quoted him as saying.
He pointed to high costs of treatment in some cases and said “the ministry alone cannot address all the problems of the health sector.” Government’s financial resources are stretched to the limit and therefore contributions from benefactors is essential, he added.
